Skip to content
Genemod logo — Modern day lab inventory and project management on a single,...

Genemod

Modern day lab inventory and project management on a single, shared platform.

Founded 2018 United States Seattle, United States 6 employees Seed Total: $8.20M Biotechnology, Cloud Infrastructure +2

General Information

Company Name Genemod
Founded Year 2018
Location United States Seattle, United States
Employees 6
Industries Biotechnology, Cloud Infrastructure, Health Care +1
Funding Stage Seed
Business Model B2B, SaaS, Platform
Revenue Model Subscription, Tiered Pricing, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with Genemod. To contact Genemod, visit genemod.net.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Genemod compare?

A PDF of Genemod and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Genemod soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Genemod

Genemod, founded in 2018 and headquartered in the United States, is a startup at the forefront of life sciences innovation. With its slogan, "Modern day lab inventory and project management on a single, shared platform," the company aims to revolutionize how scientific teams collaborate and manage their processes.

The company operates across several key industries: Biotechnology, Cloud Infrastructure, Health Care, and Life Sciences. Genemod's platform simplifies and enhances R&D efforts by offering an integrated, hybrid workspace designed to minimize repetitive tasks, thereby allowing scientists more time to focus on pioneering research.

Genemod caught investor interest with a recent $4.50M Seed Round investment on 01 May 2023. Key investors include Looking Glass Capital, Vulcan Capital, Dolby Ventures, LDV Partners, Futureland Ventures, and Defy.vc. This strategic funding positions Genemod to further enhance its platform, making it an appealing investment opportunity for those looking to support cutting-edge solutions in scientific research and development.

Business keywords: lab management, collaboration platform, life sciences R&D, scientific tools, data processing algorithms, workflow optimization, research lab operations, user-centered technology, scientific collaboration, Seattle-based startup, hybrid workspace, process management, startup technology

Services & Products

Inventory Management
Sample Tracking
Experiment Documentation
Data Migration
Protocol Template Creation
AI-Driven Workflow Automation
Order and Consumables Management
Compliance and Audit Trail Maintenance

Target Customers

Biopharmaceutical Companies Industrial Biotech Firms Clinical Research Organizations Biomanufacturers Biorepositories Academic Institutions Scientific Startups

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $4.50M 6
Looking Glass Capital, Vulcan Capital +4
01 May 2023
Seed Round $2.00M 2
Looking Glass Capital, Defy.vc
01 Aug 2022
Seed Round $1.70M 2
Canaan Partners, Amino Capital
13 Oct 2020

Genemod Alternatives & Competitors

View All Alternatives
Genemod vs
L7 Informatics
L7 Informatics United States

L7|ESP® is a Unified Platform with Workflow Orchestration and Data Contextualization, grounded in FA...

Series C
150 employees
Big Data, Biotechnology
Genemod vs

SciNote is a top-rated ELN platform for researchers in industry, academic, and federal labs 🔬

38 employees
Biotechnology, Life Sciences
Genemod vs
LabFellows
LabFellows United States

Do More Science.

Seed
4 employees
Biotechnology, Life Sciences

FAQ About Genemod

Modern day lab inventory and project management on a single, shared platform.
Genemod was founded in 2018.
Genemod is headquartered in Seattle, United States.
Genemod operates in Biotechnology, Cloud Infrastructure, Health Care and Life Sciences. Its work centres on lab management, collaboration platform, life sciences R&D and scientific tools. Its customers include Biopharmaceutical Companies, Industrial Biotech Firms and Clinical Research Organizations.
Genemod has a B2B, SaaS and Platform business model. Its revenue comes from Subscription, Tiered Pricing and Service Fee.
Genemod has approximately 6 employees.
Genemod has completed 3 funding rounds, raising a total of $8.20M. The latest funding stage is Seed.
Genemod offers: Inventory Management, Sample Tracking, Experiment Documentation, Data Migration, Protocol Template Creation, AI-Driven Workflow Automation, Order and Consumables Management, Compliance and Audit Trail Maintenance.
Top alternatives and competitors to Genemod include L7 Informatics, SciNote - Electronic Lab Notebook, LabFellows, ONTOFORCE, Benchling. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Genemod and L7 Informatics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Genemod, https://bouncewatch.com/company/genemod, updated 19 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout